Literature DB >> 12847064

Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.

Gualtiero Palareti1, Cristina Legnani, Benilde Cosmi, Lelia Valdré, Barbara Lunghi, Francesco Bernardi, Sergio Coccheri.   

Abstract

BACKGROUND: We have shown that normal D-dimer levels obtained after the discontinuation of oral anticoagulant treatment (OAT) has a high negative predictive value for recurrent venous thromboembolism (VTE). The aim of the present study was to assess the predictive value of D-dimer for recurrent VTE in subjects with a previous unprovoked event who are either carriers of inherited thrombophilia or not. METHODS AND
RESULTS: We prospectively evaluated 599 patients (301 males) with a previous VTE episode. They were repeatedly examined for D-dimer levels after OAT withdrawal and were screened for inherited thrombophilic alterations. Alterations were detected in 130 patients (21.7%), factor V Leiden (70 patients; 2 of whom were homozygotes) and prothrombin mutation (38 patients) were the most prevalent ones. Recurrent events were recorded in 58 subjects (9.7%) during a follow-up of 870.7 patient-years. Altered D-dimer levels at 1 month after OAT withdrawal were associated with a higher rate of subsequent recurrence in all subjects investigated, especially in those with an unprovoked qualifying VTE event (hazard ratio, 2.43; 95% confidence interval, 1.18 to 4.61) and in those with thrombophilia (hazard ratio, 8.34; 95% confidence interval, 2.72 to 17.43). The higher relative risk for recurrence of altered D-dimer was confirmed by multivariate analysis after adjustment for other risk factors. The negative predictive value of D-dimer was 92.9% and 95.8% in subjects with an unprovoked qualifying event or with thrombophilia, respectively.
CONCLUSIONS: D-dimer levels measured 1 month after OAT withdrawal have a high negative predictive value for recurrence in subjects with unprovoked VTE who are either carriers or not carriers of congenital thrombophilia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12847064     DOI: 10.1161/01.CIR.0000079162.69615.0F

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  37 in total

1.  D-dimer for the diagnosis of pulmonary embolism: a call for sticking to evidence.

Authors:  Grégoire Le Gal; Henri Bounameaux
Journal:  Intensive Care Med       Date:  2004-10-14       Impact factor: 17.440

2.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 3.  Update in general internal medicine.

Authors:  Toshiko Uchida; Stephen D Persell; David W Baker
Journal:  J Gen Intern Med       Date:  2009-10-28       Impact factor: 5.128

4.  Carbohydrate antigens as potential biomarkers for the malignancy in patients with idiopathic deep venous thrombosis: a retrospective cohort study.

Authors:  Miao Yu; Yun-Hong Wang; Ahmed M E Abdalla; Wen-Qi Liu; Fei Mei; Jian Wang; Chen-Xi Ouyang; Yi-Qing Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-10-16

Review 5.  Diagnosis of deep vein thrombosis, and prevention of deep vein thrombosis recurrence and the post-thrombotic syndrome in the primary care medicine setting anno 2014.

Authors:  Jan Jacques Michiels; Janneke Maria Michiels; Wim Moossdorff; Mildred Lao; Hanny Maasland; Gualtiero Palareti
Journal:  World J Crit Care Med       Date:  2015-02-04

Review 6.  Duration of anticoagulation after cerebral venous sinus thrombosis.

Authors:  Frances Caprio; Richard A Bernstein
Journal:  Neurocrit Care       Date:  2012-04       Impact factor: 3.210

7.  Early detection of venous thromboembolism in patients with neuroepithelial tumor: efficacy of screening with serum D-dimer measurements and Doppler ultrasonography.

Authors:  Tomohiro Kawaguchi; Toshihiro Kumabe; Masayuki Kanamori; Taigen Nakamura; Ryuta Saito; Yoji Yamashita; Yukihiko Sonoda; Mika Watanabe; Teiji Tominaga
Journal:  J Neurooncol       Date:  2010-06-29       Impact factor: 4.130

Review 8.  Acute pulmonary embolism. Part 2: treatment.

Authors:  Josien van Es; Renée A Douma; Victor E A Gerdes; Pieter W Kamphuisen; Harry R Büller
Journal:  Nat Rev Cardiol       Date:  2010-09-14       Impact factor: 32.419

9.  Use of D-dimer testing to determine duration of anticoagulation, risk of cardiovascular events and occult cancer after a first episode of idiopathic venous thromboembolism: the extended follow-up of the PROLONG study.

Authors:  Benilde Cosmi; Cristina Legnani; Alberto Tosetto; Vittorio Pengo; Angelo Ghirarduzzi; Adriano Alatri; Domenico Prisco; Daniela Poli; Armando Tripodi; Gualtiero Palareti
Journal:  J Thromb Thrombolysis       Date:  2009-03-14       Impact factor: 2.300

10.  Prospective study of plasma D-dimer and incident venous thromboembolism: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Aaron R Folsom; Alvaro Alonso; Kristen M George; Nicholas S Roetker; Weihong Tang; Mary Cushman
Journal:  Thromb Res       Date:  2015-08-28       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.